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Background: Spermatozoa morphology is an important and complex characteristic of the fertilization capacity of
male germ cells. Morphological abnormalities have been observed to be accompanied by reactive oxygen species
(ROS) overproduction and further damage to spermatozoa, ultimately leading to infertility. Therefore, this study
aimed to examine the relationship between seminal ROS production and sperm morphology in infertile
teratozoospermic patients as well as in healthy men of proven and unproven fertility.
Methods: Semen samples were collected from 79 patients classified as teratozoospermic and 56 healthy donors
(control). Standard semen analysis was performed and spermatozoa morphology was assessed according to the
WHO 2010 guidelines. Seminal ROS was measured by chemiluminescence assay. Receiver operating characteristic
(ROC) curves were generated, and sensitivity, specificity, cutoff value and area under curve (AUC) were determined.
Results: Sperm morphology was significantly poor in the Teratozoospermic Group compared with the 3 Donor
Groups (P < 0.05). Significantly higher levels of ROS (RLU/sec/106 sperm) were seen in the Teratozoospermic group
(145.4 (41.5; 555.4) compared to the Donor Groups: All Donors (64.8 (21.1; 198.2), Proven Donors (58.8 (14.2; 79.2)
and Proven Donors < 2 years (58.8 (14.2; 79.2) (P < 0.05). ROS correlated negatively with sperm concentration in the
All Donor group (r = −0.354; P = 0.021) as well as in the Teratozospermic group (r −0.356; P = 0.002). Using ROC
analysis, we established the cutoff values for concentration, morphology and ROS.
Conclusions: The incidence of teratozoospermia may be directly related to the overproduction of seminal ROS.
Therefore, besides sperm concentration and motility, spermatozoa morphology should receive an equally important
consideration in the overall assessment of male fertility.
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Increasing fertilization incompetence has become a major
concern for males and females of reproductive age. As
male factor is thought to contribute to approximately
40% of all infertility cases, an accurate semen analysis
should be the keystone of the assessment of male
fertilization potential [1,2].
Sperm count and sperm motility are typically the first
diagnostic markers to be evaluated when studying semen
quality. Morphology of the sperm cell is an underrated
semen parameter, mainly because of the lack of a commonly
accepted evaluation method as well as a general cut-off
value [2-4]. Nevertheless, the morphologic characteristics of* Correspondence: agarwaa@ccf.org
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unless otherwise stated.the sperm cell are the outcome of highly complex cellu-
lar modifications occurring during spermatogenesis
[3,5,6]. The resulting percentage of abnormal spermatozoa
as well as specific structural abnormalities may serve as an
indicator of a defective mechanism related to spermatozoa
production and/or maturation [1] and is a valuable pre-
dictor of spontaneous pregnancies and fertilization success
in assisted reproductive technology (ART) [7-9]. Further-
more, abnormal spermatozoa morphology has been linked
not only to a decrease of traditional parameters of semen
quality [10-12] but also to an increase in contemporary
markers of sperm damage, such as DNA fragmentation
[1,2] or reactive oxygen species (ROS) overproduction
[13,14].
A common origin of both pathological spermatozoa and
ROS may be found within the sperm membrane remodelingl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Agarwal et al. Reproductive Biology and Endocrinology 2014, 12:45 Page 2 of 8
http://www.rbej.com/content/12/1/45during spermatogenesis. Due to failures in the process,
such as abnormal head-tail attachments, incomplete ac-
rosomal development or alterations in the sperm cyto-
skeleton [15], spermatozoa exhibit cytoplasmic residues
leading to the creation of both morphologically abnor-
mal structures as well ROS [16]. Pathological spermato-
zoa, together with leukocytes, are considered to be the
primary source of free radicals in semen [14,17,18].
Additionally, ROS overproduction has been linked to
oxidative damage of the poorly protected sperm cell.
The polyunsaturated fatty acids (PUFA), present in
large quantities in the cytoplasmic membrane of sperm-
atozoa, are the primary target for deleterious peroxida-
tion, which leads to a decreased membrane fluidity and
further structural defects of the sperm cell [19,20].
Although several studies have highlighted an association
between spermatozoa morphology and ROS present in
semen [16,21,22], the exact mechanism linking both the
abnormal sperm morphological forms and the oxidative
balance within the sperm cell have not been investigated.
Therefore, in this study, we examined the relationship be-
tween seminal ROS production and sperm morphology in
infertile teratozoospermic patients as well as in healthy
men of proven and unproven fertility. The results may
confirm the complex biological relationship between tera-
tozoospermia and oxidative stress and possibly help to ex-
plain the causes of male infertility in some men.
Methods
Following approval from the Cleveland Clinic Institu-
tional Review Board (IRB), 135 subjects were enrolled in
the study: 56 healthy male volunteers and 79 patients di-
agnosed with teratozoospermia (percentage of spermato-
zoa with < 4% normal morphology).
The inclusion criteria for the infertile patients were as
follows: all subjects attended the male infertility clinic
for fertility issues. All of these men were evaluated for
proven male-factor infertility as assessed the male infer-
tility specialist. All of them underwent history, physical
and laboratory evaluation. None of them had female fac-
tor infertility in their partners. Our exclusion criteria
were: azoospermia, incomplete semen analysis results or
inadequate semen sample for ROS measurement.
The donors were healthy males, 20 – 35 years old
whose semen samples fulfilled the criteria established by
the WHO 2010 guidelines for semen analysis i.e. normal
semen parameters [23]. Of the 56 donors, 28/56 (50%)
were of proven fertility (having established a successful
pregnancy in the past), and 16/56 (28.6%) had initiated a
pregnancy in the past 2 years.
The inclusion criteria for the All Donor group were: 1)
normal semen parameters; 2) no sexually transmitted in-
fections; 3) no recreational drug use, and 4) may or may
not have initiated a pregnancy in the past. The ProvenDonor group (n = 28) included men who had initiated a
pregnancy at some point. The inclusion criteria were: 1)
normal semen parameters; 2) no sexually transmitted in-
fections; 3) no recreational drug use and 4) Initiated a
pregnancy in the past. The third donor group (Proven
Donors < 2 years) (n = 12) included men who had initi-
ated a pregnancy in the past two years. The Inclusion
criteria were: 1) normal semen parameters; 2) no sexu-
ally transmitted infections; 3) no recreational drug use
and 4) initiated a pregnancy within the past 2 years. The
exclusion criteria for the donors were the following:
azoospermia, incomplete semen analysis results or inad-
equate semen sample for measurement of ROS.
Semen analysis
Semen samples were collected by masturbation after 2–3
days of sexual abstinence. After liquefaction, a complete
semen analysis was performed to evaluate the sperm pa-
rameters according to the World Health Organization
(WHO) guidelines [23]. Sperm concentration and percent-
age motility analysis were done using a MicroCell count-
ing chamber (Vitrolife, San Diego, California).
Measurement of white blood cells
The presence of peroxidase positive leukocytes (neutro-
phils and macrophages) in semen was assessed by a
myeloperoxidase- staining test. 20 μL of liquefied semen
specimen was mixed well with 20 μL of phosphate-
buffered saline (PBS) (pH 7.0) and 40 μL of benzidine solu-
tion. The mixture was allowed to sit at room temperature
for 5 minutes. Peroxidase positive leukocytes that stained
brown were counted by a Makler counting chamber (Sefi
Medical, Haifa, Israel) under a bright-field objective (mag-
nification, × 20). The results after correction for dilution
were recorded as × 106 peroxidase-positive leukocytes/mL
of semen. A seminal leukocyte concentration of ≤1 ×
106WBC/mL was considered normal [23].
Assessment of sperm morphology
Thin smears of the well-mixed ejaculated semen were pre-
pared in duplicate by placing 2–5 μL (depending on the
sperm concentration) on clean slides. After air drying, the
slides were stained using Diff-Quik kit (Baxter Healthcare
Corporation, Inc., McGaw Park, IL) and graded on the
basis of the Kruger’s Strict criteria and cutoff value estab-
lished by WHO 2010 guideline [23]. A total of 100 sperm-
atozoa were scored per slide using bright field illumination
and an oil immersion objective with a total magnification
of × 2000. At least ten high-power fields selected at ran-
dom from different areas of the slide were examined.
Measurement of reactive oxygen species
ROS levels in seminal ejaculates were measured by chemi-
luminescence assay using luminol (5-amino-2, 3- dihydro-1,
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The test samples consisted of luminol (10 μL, 5 mM)
and 400 μL of semen. Negative controls were prepared
by replacing the sperm suspension with 400 μL phosphate
buffered saline. Positive control included 400 μL of PBS
and 50 μL of hydrogen peroxide (30%; 8.8 M) in tripli-
cates. Chemiluminescence was measured for 15 min using
a Berthold luminometer (Autolumat Plus 953, Oakridge,
TN). The results were expressed as relative light units
(RLU)/sec/106 sperm [24].
Statistical analysis
The data were analyzed using inbuilt functions within
the Statistical Package for Social Science (SPSS UK Ltd.,
Chertsey, Surrey, UK). Summary statistics are presented
as mean and standard deviation (SD). Univariate com-
parison of continuous variables among the groups was
performed with the Kruskal-Wallis test. Simultaneous
multiple pairwise comparisons among groups were per-
formed with the Conover–Inman test, which is simply
Fisher’s least significance difference method performed
on ranks. Spearman’s rank correlation test was used to
provide a distribution-free test of independence between
sperm ROS production and sperm attributes. All hy-
pothesis testing was two-tailed; P < 0.05 was considered
statistically significant. Forward stepwise logistic regres-
sion analysis was used to identify a suitable model pre-
dicting high sperm ROS production.
Results
Semen parameters
Tables 1, 2 and 3 represent the sperm parameters in three
healthy donor groups (unproven fertility, any proven
fertility, and proven fertility within the previous 2 years)
as compared to the teratozoospermic patients. While
the spermatozoa concentration was not significantly dif-
ferent between the patients and the donors, a significant (P
< 0.05) decrease in the seminal volume was observed in the
Teratozoospermic Patients (3.27 ± 1.62 mL) as compared
with the Proven Donors (4.24 ± 2.13 mL) and Proven Do-
nors < 2 years (5.03 ± 2.22 mL). Spermatozoa motility was
higher in the Teratozoospermic group (57.66 ± 12.33%)Table 1 Comparison of semen parameters (mean ± SD) in All
Parameter All donors Teratozoospermic pati
Volume (mL) 3.36 ± 2.02 3.27 ± 1.62
Concentration (× 106/mL) 54.26 ± 32.19 60.64 ± 53.58
Motility (%) 53.70 ± 15.00 57.66 ± 12.33
Normal morphology (%) 6.93 ± 3.91 1.52 ± 1.12*
Endtz test (WBC/mL) 1.04 ± 2.54 0.25 ± 0.87
ROS (RLU/sec/106 sperm) 64.8 (21.1; 198.2)** 145.4 (41.5; 555.4)*; *
*Significant if P < 0.05; **Values are represented as median (25th, 75th percentile).compared with both Proven Donors (50.85 ± 13.52%)
and Proven Donors < 2 years (49.88 ± 8.68%).
The highest percentage of morphologically normal
spermatozoa was seen in Proven Donors followed by All
Donors (Tables 1, 2, 3). Significantly lower percentages
of morphologically normal spermatozoa were seen in the
Teratozoospermic group (1.52 ± 1.12%) when compared
to all three Donor groups (P < 0.05) (Tables 1, 2, 3).
Sperm morphology was positively correlated with concen-
tration in Donor groups (P = 0.009; P = 0.037 and P = 004,
respectively). Similarly, normal morphology was correlated
with motility in All Donors (P = 0.001) and Proven Donors
(P = 0.032). Furthermore, a significant correlation was
found between spermatozoa morphology and semen vol-
ume in Teratozoospermic Patients (P = 0.044) (Table 4).
The sensitivity, specificity, cutoff value and area under
curve (AUC) for the three donor groups and teratozoos-
permic patients are shown in Tables 1, 2, 3. Sperm
morphology showed high specificity and AUC. The cut-
off values for concentration were similar in the 3 Donor
groups (41.7, 41.75 and 41.75 × 106/mL). Morphology
also had a similar cutoff value of 3.5% in the 3 Donor
groups and Teratozoospermic group.
ROS production
All the Donor groups were characterized by normal ROS
levels, as shown in Tables 1, 2, 3 as well as Figure 1. The
lowest ROS values (median (25th, 75th percentile) were de-
tected in proven donors < 2 years (58.8 (14.2; 79.2) RLU/
sec/106 sperm). The highest ROS production was recorded
in the Teratozoospermic patients group (145.4 (41.5; 555.4)
RLU/sec/106 sperm), (P < 0.05) in comparison with all
donor groups. Furthermore the ROS production was nega-
tively correlated with the spermatozoa concentration in All
Donors (r = −0.354; P = 0.021) as well as Teratozoospermic
Patients (r = −0.356; P = 0.002; Table 4).
The sensitivity, specificity, cutoff value and area under
curve (AUC) for ROS in the 3 Donor groups and Terato-
zoospermic Patients is shown in Tables 1, 2, 3 and Figure 1.
ROS showed high specificity and AUC in the Proven Do-
nors < 2 years and Teratozoospermic group. Sensitivity was
comparable in all the groups. The cutoff value was 85.9,Donors (n = 56) and Teratozoospermic Patients (n = 79)
ents Sensitivity (%) Specificity (%) Cutoff value AUC value
89.7 23.2 5.0 0.482
55.7 63.6 41.7 0.529
25.3 77.8 45.5 0.400
100 78 3.5 0.916
N/A N/A N/A N/A
* 63.9 65.1 85.9 0.614
Table 2 Comparison of semen parameters (mean ± SD) in Proven Donors (n = 28) and Teratozoospermic Patients (n = 79)
Parameter Proven donors Teratozoospermic patients Sensitivity (%) Specificity (%) Cutoff value AUC
Volume (mL) 4.24 ± 2.13 3.27 ± 1.62* 89.7 35.7 5.0 0.633
Concentration (× 106/mL) 60.07 ± 33.44 60.64 ± 53.58 55.7 71.4 41.7 0.578
Motility (%) 50.85 ± 13.52 57.66 ± 12.33* - - - -
Normal morphology (%) 7.00 ± 4.35 1.52 ± 1.12* 100 73.7 3.5 0.913
Endtz test (WBC/mL) 0.00 ± 0.00 0.25 ± 0.87 N/A N/A N/A N/A
ROS (RLU/sec/106 sperm) 75.8 (33.3; 147.8)** 145.4 (41.5; 555.4)*; ** 61.1 70.4 95.3 0.638
*Significant if P < 0.05; **Values represented as median (25th, 75th percentile).
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compared with Teratozoospermic group (Figure 1).
Discussion
Of male patients referred for fertility evaluation, 25-50%
are diagnosed with idiopathic infertility [5,6,25]. There-
fore, an accurate semen analysis plays a crucial role in the
management of infertile couples and treatment options.
Ideally, the three traditional markers of semen quality
(sperm count, motility, morphology) should be strongly
interrelated to reflect their contribution to a successful
fertilization. However, it is known now, that even if the
sperm concentration or motility is good, a morpho-
logical defect may be the single most important factor
reflecting the actual fertilization capacity of the sperm.
(Tables 1, 2, 3) [6,10,18,20]. While positive correlations
have been found mainly in in vivo studies, negative asso-
ciations and the independent character of morphology
has been also been demonstrated with fertilization suc-
cess. Therefore, it is necessary to point out both – the
status of morphology within the traditional semen pa-
rameters as well as its status as an individual marker.
[4,25-27].
The patient population in this study presented with
good sperm count and motility but poor morphology,
relating to previous observations that this parameter
may reflect best the actual ability of the sperm cell to
successfully fertilize the oocyte [28]. In fact, strict
morphology has become a significant prognostic valueTable 3 Comparison of semen parameters (mean ± SD) in Pro
Patients (n = 79)
Parameter Proven donors <2 y Teratozoospermic pa
Volume (mL) 5.03 ± 2.22 3.27 ± 1.62*
Concentration (× 106/mL) 61.59 ± 23.93 60.64 ± 53.58
Motility (%) 49.88 ± 8.68 57.66 ± 12.33*
Normal morphology (%) 6.77 ± 4.95 1.52 ± 1.12*
Endtz test (WBC/mL) 0.00 ± 0.00 0.25 ± 0.87
ROS (RLU/sec/106 sperm) 58.8 (14.2; 79.2)** 145.4 (41.5; 555.4)*
*Significant if P < 0.05; **Values are represented as median (25th, 75th percentile).in assisted reproduction, as in the case of intrauterine
insemination [29], in vitro fertilization (IVF) [9,30] and
intracytoplasmic sperm injection (ICSI) [7,31]. Regard-
less of the assisted reproductive technique selected,
using spermatozoa with morphological abnormalities
leads to lower fertilization and pregnancy rates, as well
as a higher risk of fetal DNA damage [28-31].
As traditional markers of semen quality have been de-
fined and studied on numerous occasions, attention is
driven towards new and alternative diagnostic tools,
such as the evaluation of free radical production, provid-
ing explanations to the gaps between semen quality and
the actual fertilization potential [13,14,16,21]. Our re-
sults show significant differences in the ROS levels be-
tween the Teratozoospermia group and all the Donor
groups (Tables 1, 2, 3).
Overproduction of ROS and oxidative damage to the
sperm cell has been acknowledged as one of the leading
causes and/or secondary complications connected to the
decreasing fertility potential in males [32]. Low levels of
ROS (physiological levels) are needed to promote essential
signaling pathways to promote spermatozoa maturation,
capacitation, hyperactivation and acrosome reaction [33].
Excessive levels of ROS in the male reproductive sys-
tem may be generated by two sources: immature and/or
pathological spermatozoa and activated leukocytes. Leu-
kocytes are known to generate significantly larger levels
of ROS. Immature and/or pathologic spermatozoa in
males with sperm abnormalities are expected to make aven Donors < 2 years (n = 16) and Teratozoospermic
tients Sensitivity (%) Specificity (%) Cutoff value AUC value
89.7 50 5.0 0.746
55.7 87.5 41.7 0.652
27.8 75 46.5 0.33
100 69.2 3.5 0.883
N/A N/A N/A N/A
; ** 61.1 93.8 95.3 0.73
Table 4 Correlations between the semen quality parameters, spermatozoa morphology and ROS production in the
Donor and Teratozoospermia groups
Experimental group Parameter (1) Parameter (2) n Spearman correlation P-value
All Donors Normal morphology Concentration 56 0.407 0.009
Normal morphology Motile sperm 56 0.508 0.001
ROS Concentration 56 −0.354 0.021
Proven Donors Normal morphology Concentration 28 0.481 0.037
Normal morphology Motile sperm 28 0.494 0.032
Proven Donors < 2 y Normal morphology Concentration 16 0.733 0.004
Teratozoospermic Patients Motility Concentration 79 0.346 0.002
Teratozoospermic Patients Normal morphology Volume 79 0.228 0.044
Teratozoospermic Patients ROS Concentration 79 −0.356 0.002
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normospermic males, as reflected by Gil-Guzman et al.
[34] and Oborna et al. [18].
We evaluated the leukocyte concentration using the
peroxidase or the Endtz test. We did not separate leuko-
cytes from the seminal ejaculates when performing the
ROS measurement. The Endtz test result in our study
shows that the concentration of peroxidase-positive cells
in teratozoospermic subjects was very low and non-
significant when compared to the Donor Group. In fact,
the concentration of 0.25 ± 0.87 × 106 wbc/mL was
lower than in the All Donor group (1.04 ± 2.54 wbs/mL)
although not significant and furthermore coupled with
the WHO threshold of 1.0 × 106 wbc/mL. We did not
classify sperm abnormalities into head, mid-piece and
tail abnormalities according to the WHO 1999 criteria.
However, based on this observation, we assume that the
ROS overproduction in the Patient Group was relatedFigure 1 Receiver operator characteristic (ROC) curves for ROS in (A)
fertility vs. Teratozoospermia group. ROC curves shows the area under
compared to All Donors, Proven Donors, and Proven Donors who had initiprimarily to the high occurrence of spermatozoa malfor-
mations. Moreover, none of the patients had elevated
levels of white blood cells in the ejaculate and there the
source of ROS was largely a product of increased ROS
from the spermatozoa. High ROS production in the ab-
sence of leukocytes especially the granulocytes indicates
the source of high ROS to be morphologically abnormal
spermatozoa. This may also clarify the hypothesis that the
cytoplasmic membrane could be the primary structure to
be involved in morphological abnormalities of the sperm-
atozoa. At the same time, it is the main sperm structure to
be attacked by ROS [35].
Our data may supplement previous reports showing
association between defective sperm function and excess
cytoplasmic enzymes such as superoxide dismutase, lac-
tic acid dehydrogenase and creatine kinase and glucose-
6-phosphate dehydrogenase [21,33,36-39]. These are dir-
ectly involved in the oxidative balance of spermatozoaAll Donors; (B) Proven Donors and (C) Proven Donors < 2 years
the curve for ROS production in Patients with teratozoospermia when
ated pregnancy in the last two years.
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tive damage to the sperm cell [40,41]. Furthermore,
Ghani et al. [42] showed a significantly elevated expres-
sion of NOX5, a novel NADPH-oxidase and prime can-
didate for the ROS production in the acrosomal,
equatorial, post-acrosomal regions of abnormal sperm-
atozoa. Moreover, a significant positive correlation was
observed between the NOX5 activity and the frequency
of sperm with abnormal morphology.
Interestingly, no significant correlation was found be-
tween ROS production and spermatozoa motility, an ob-
servation contrary to a number of studies performed on
ejaculates from healthy males as well as infertile patients
[17,18,21,22]. On the other hand, Whittington et al. [43]
as well as Desai et al. [44] found no correlation between
the motility parameters and ROS assuming that similarly
to the spermatozoa morphology, seminal ROS might be
an independent marker of fertility in clinical settings.
Moreover, significant connections between spermatozoa
morphology and ROS were recorded in these studies
proving strong interrelations between the two parame-
ters, similar to our results (Table 4).
This study has enabled us to define the cutoff values
as well as the sensitivity, specificity and the area under
curve (AUC) for a variety of sperm characteristics, in-
cluding morphology as well as for ROS comparing the
Donor and Teratozoospermic groups. This information
is important as the cutoff values may be used when
identifying the different patients and donors in the fu-
ture. Furthermore, we have established the cutoff values
for ROS in the general donor and patient population but
not specifically comparing concrete subsets of donors
with unproven and proven fertility and a subset of infer-
tile men exhibiting teratozoospermia.
Several earlier studies [45-49] have used the ROC curves
to demonstrate the importance in establishing the cutoff
and threshold values for different semen parameters based
on clinical, rather than empiric data. Using ROC curve
analysis, Ombelet et al. [45] showed that the sperm
morphology was the best semen parameter with the high-
est prediction power (AUC= 78%) and a cutoff value of
10%. A similar threshold value was detected by Günalp
et al. [46] with an AUC of 69.7%. On the contrary, and
similar to our results, Menkveld et al. [47] found a much
lower cutoff value for morphology (4%), but with a good
predictive value based on an AUC of 78.2%.
Moreover, Guzick et al. [48], using the CART analysis,
was able to establish a cutoff value for spermatozoa
morphology in fertile (>12%) as well as in subfertile sub-
jects (<9%). Their ROC curve analysis showed that
morphology had the best predictive power based on an
AUC of 66%.
The ROC analysis for the ROS production has been per-
formed in a few studies only. According to Allamaneniet al. [49], the optimum ROS cutoff value to identify pa-
tients with oxidative stress in neat semen was 0.185 ×
106 cpm/20 × 106 sperm, with an AUC value from 0.57–
0.80. Furthermore, in the study by Desai et al. [50] the cal-
culated ROS cutoff value to differentiate between fertile
and infertile subjects was 0.0185 × 106 cpm/20 × 106
sperm, with the unadjusted positive predictive value of
82.4% and the negative predictive value of 77.8%. Simi-
larly, we have established the ROS cutoff value in the sem-
inal ejaculate of 93 RLU/sec/106 sperm with a specificity
of 70.4% and sensitivity of 61.4% and area under curve of
68% [24,51]. Our AUC values varied between 61.4% and
73%, proving conclusions from both manuscripts [24,51]
that the ROS measurement has an important clinical rele-
vance as a test used for infertility screening.
Conclusions
Based on the compatibility of results from our study along
with previous observations, we strongly support the hy-
pothesis that there is a direct relationship between sperm-
atozoa morphology and oxidative balance. Disturbances in
spermatozoa production and maturation may have a dra-
matic impact on the structural characteristics as well as free
radical production in semen. Furthermore, we emphasize
that spermatozoa morphology is probably the most rele-
vant parameter of traditional semen evaluation, providing
information of the fertilization potential, which in combin-
ation with modern markers of semen quality, such as ROS
production, may have the best indication value of poor
semen quality in the laboratory assessment of infertile men.
At the same time, we suggest further comparative studies
connecting the spermatozoa morphology and ROS produc-
tion with further markers of semen quality, such as DNA
integrity or seminal antioxidant status.
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